In a remarkable medical and technical development, a 41-year-old patient underwent a pioneering clinical study within a joint project between… UCHealth andUniversity of Colorado Anschutz Medical Campuswith the aim of testing brain-computer interface (BCI) technology in patients with hemiplegia.

The patient has been suffering from complete paralysis in the lower part of his body since a traffic accident in 2017, but he was recently able to feel an imaginary movement in his fingers, despite the absence of any actual physical movement.

According to the medical team, the new technology relies on implanting an advanced brain interface that is not limited to the traditional motor areas of the brain, but also targets higher areas responsible for intention, planning, and decision-making, which allows the system to understand “the patient’s intention” instead of being limited to reading muscle signals only.

This technology works as a neural translator that records electrical signals in the brain and converts them into commands that can be used to control external devices such as computers or robotic prosthetics.

The system also provides a type of “sensory feedback,” which helped the patient feel the sensation of the movement of his fingers through what is known as an illusory sensation, in a step described as an important development in reconnecting the brain and the body.

Dr. Daniel Kramer, a specialist in neurosurgery, said UCHealthThis progress is not limited to serving patients only, but also opens new horizons for understanding how the human brain works in the areas of thinking, planning, and daily movement.

Patterson is currently undergoing extensive training to transform ideas into digital commands, such as controlling a computer cursor or executing complex virtual movements, as part of what is known as interactive learning between the brain and the machine.

The researchers hope that this long-term study will contribute to the development of future treatments for people with spinal cord injuries and neurological diseases such as amyotrophic lateral sclerosis (ALS), in addition to other neurological and cognitive disorders, with potential possibilities for a deeper understanding of the functioning of the human brain.